Biodexa Pharmaceuticals Plc financial data

Symbol
BDRX on Nasdaq
Location
Cardiff
Fiscal year end
31 December
Latest financial report
20-F - Q4 2024 - 11 Apr 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6,685,918,822 shares 462%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets £14,780,000 GBP 40%
Liabilities £6,458,000 GBP 10%